Kelly Clarkson will tell you: What doesn’t kill you makes you stronger. And now, after more than a century of antibiotic warfare, the plucky Neisseria Gonorrhoeae bacteria, the author of Gonorrhea, has developed a resistance to most antibiotics used to combat it. That is why the Oxford University team that helped develop AstraZeneca’s COVID-19 vaccine is moving on to fighting The Clap.
Why is Gonorrhea, a particularly nasty STD that is part of the routine testing regimen at adult industry lab Talent Testing Services (TTS), called “The Clap”? The dominant theory, of a few, comes from the word clapier, which is French for rabbit nest and, because rabbits are always having sex, became the term of choice for French brothels.
Having never had gonorrhea myself, I still would relish the opportunity to say, “My junk has gone all Watership Down.”
Neisseria Gonorrhoeae is now known as a “priority pathogen,” according to the Centers for Disease Control, noting that infections have jumped 63 percent since 2014, resulting in about 280,000 U.S. cases annually. The average dose of a 250 mg. cocktail of ceftriaxone and 1 gram of azithromycin has been replaced with a 500 mg injection of ceftriaxone in just ten years, as Gonorrhea, like the bullied, mousey doormat on the playground, has grown and flourished under your constant abuse.
The Boston University-based foundation CARB-X (Combating Antibiotic-Resistant Bacteria) has awarded the Oxford team $2 million to develop a “super gonorrhea” vaccine, and the group, fresh off their rollout of Europe’s predominant C!( vaccine, hopes to begin human trials of their Gonorrhea drug by 2024.
Previously on Porn Valley Observed: Despite ban, Porn Valley still using the word “Jugs”
See Also: Centers for Disease Control—Gonorrhea, CARB-X, A ‘super gonorrhea’ vaccine in pipeline; Team AstraZeneca that developed COVID-19 shots at work (Time Now News)
Leave a Reply